Agoracom: Small Cap Investment - Pluristem Life Systems, Inc. - Re: Cardiac Function in Pre-Clinical Diabetic Diastolic Heart Failure Improves with

patented technology to grow and expand adult Stem Cells

Adult stem cell development company commencing clinical trials applicable to estimated $30 billion degenerative disease market place

Reply New Message

Back To Forum List View

Cardiac Function in Pre-Clinical Diabetic Diastolic Heart Failure Improves with

greybeard

May 15, 2012 09:37AM

emit

Rank: Vice President [?]

Points: 41186 [?]

Votes: 199 Score: 3.0 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Cardiac Function in Pre-Clinical Diabetic Diastolic Heart Failure Improves with

in response to

Cardiac Function in Pre-Clinical Diabetic Diastolic Heart Failure Improves with

greybeard

posted on May 15, 2012 02:37PM

OKAY -- We got a stock full of Favor here...

Bet they find another terminal patient with this and treat them.

I pray for this company every day.

emit...

Reply New Message

Back To Forum List View

Please to post a reply